Medical College of Wisconsin at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Medical College of Wisconsin takes part in 4 sessions at ASH 2026 in New Orleans. Its program centres on treatment choices across blood cancers, from CAR T standards for lymphoma to the order of T-cell engagers and newer CAR T in relapsed myeloma. It also covers molecular monitoring and long-term quality of life in chronic myeloid leukemia.
| Organization | ASH 2026 Attendance |
|---|---|
Medical College of Wisconsin Milwaukee, WI | |
Private medical school and biomedical research institution in Milwaukee, Wisconsin. | Symposium Fri Dec 11 7:00pm–10:00pm Accelerating CARs for Lymphoma: Expert Workshops on CAR-T Standards, Sequencing, and Emerging Cellular Therapy Platforms CAR-T as standard lymphoma care and what comes next, including dual-target, faster-manufactured, and in vivo versions that could widen patient access. Symposium Fri Dec 11 11:00am–2:00pm CML Treatment Continuum: Optimizing Therapy Selection, Molecular Monitoring, And Long-Term Quality of Life First-line drug choice, resistance, long-term side effects, and treatment-free remission in chronic myeloid leukemia, plus pipeline agents. Symposium Fri Dec 11 7:00am–10:00am Next in Line for Relapsed/Refractory Myeloma: Sequencing Strategies With T-Cell Engagers, Next-Generation CAR-T, and Innovative MOAs Sequencing relapsed myeloma treatments as next-generation CAR-T, multi-target T-cell engagers, and new drug classes arrive, plus managing their toxicity. |
Instantly find 20 buyers from Medical College of Wisconsin
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction